Ann Woolfrey, MD

Associate Member
Clinical Research Division
Professor, Pediatrics
University of Washington

Research Interests
Hematopoietic cell transplant (HCT) is the only curative therapy for many life-threatening hematologic diseases, and theoretically could cure other chronic hematologic and immunologic disorders. My research projects are aimed toward improving the effectiveness of hematopoietic cell transplants, particularly for patients with nonmalignant disorders. These studies explore the use of lower dose (nonmyeloablative) conditioning regimens to reduce the short and long term toxicities associated with HCT, the use of HCT to restore normal immunity in patients with HIV or refractory autoimmune diseases, and the use of alternative donors, including unrelated and mismatched related donors.


Contact Information

(206) 667-4453
(206) 667-4937
Additional contact

Mail Stop: D3-390